메뉴 건너뛰기




Volumn 3, Issue 2, 2010, Pages 85-90

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction

Author keywords

Assisted reproduction; bromocriptine; controled ovarian stimulation; OHSS

Indexed keywords

BROMOCRIPTINE;

EID: 77957002329     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.69342     Document Type: Article
Times cited : (21)

References (21)
  • 1
    • 33744539999 scopus 로고    scopus 로고
    • The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization
    • DOI 10.1016/j.fertnstert.2005.11.053, PII S0015028206003761
    • Kwee J, Schats R, McDonnell J, Schoemaker J, Lambalk CB. The Clomiphene Citrate Challenge Test (CCCT) versus the Exogenous Follicle stimulation hormone Ovarian Reserve Test (EFORT) as single test for identification of low and hyper responders to in vitro fertilization (IVF). Fertil Steril 2006;85:1714-1722 (Pubitemid 43816417)
    • (2006) Fertility and Sterility , vol.85 , Issue.6 , pp. 1714-1722
    • Kwee, J.1    Schats, R.2    McDonnell, J.3    Schoemaker, J.4    Lambalk, C.B.5
  • 2
    • 0028834945 scopus 로고
    • Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients
    • Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995;10:2432-2437
    • (1995) Hum Reprod , vol.10 , pp. 2432-2437
    • Simon, C.1    Cano, F.2    Valbuena, D.3    Remohi, J.4    Pellicer, A.5
  • 3
    • 0037383902 scopus 로고    scopus 로고
    • Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome.An aggressive, but perhaps life-saving procedure
    • Amarin ZO. Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome. An aggressive, but perhaps life-saving procedure. Hum Reprod 2003;18:659-664
    • (2003) Hum Reprod , vol.18 , pp. 659-664
    • Amarin, Z.O.1
  • 4
    • 33751247033 scopus 로고    scopus 로고
    • Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model
    • DOI 10.1210/en.2006-0657
    • Gómez R, González-Izquierdo M, Zimmermann RC, Novella-Maestre E, Alonso-Muriel I, Sanchez-Criado J, et al. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)- mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 2006;147:5400-5411 (Pubitemid 44790595)
    • (2006) Endocrinology , vol.147 , Issue.11 , pp. 5400-5411
    • Gomez, R.1    Gonzalez-Izquierdo, M.2    Zimmermann, R.C.3    Novella-Maestre, E.4    Alonso-Muriel, I.5    Sanchez-Criado, J.6    Remohi, J.7    Simon, C.8    Pellicer, A.9
  • 7
    • 0036865059 scopus 로고    scopus 로고
    • Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review
    • DOI 10.1093/humupd/8.6.559
    • Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update 2002;8:559-577 (Pubitemid 35452781)
    • (2002) Human Reproduction Update , vol.8 , Issue.6 , pp. 559-577
    • Delvinge, A.1    Rozenberg, S.2
  • 8
    • 33645847254 scopus 로고    scopus 로고
    • Serum inhibin A,VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial
    • Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial. Hum Reprod 2006;21:1260-1265
    • (2006) Hum Reprod , vol.21 , pp. 1260-1265
    • Babayof, R.1    Margalioth, E.J.2    Huleihel, M.3    Amash, A.4    Zylber-Haran, E.5    Gal, M.6
  • 9
    • 38049170879 scopus 로고    scopus 로고
    • The use of gonadotrophin-releasing hormone (9GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in highrisk patients undergoing in vitro fertilization syndrome: A prospective randomized controlled study
    • Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotrophin-releasing hormone (9GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in highrisk patients undergoing in vitro fertilization syndrome: A prospective randomized controlled study. Fertil Steril 2008;89:84-91.
    • (2008) Fertil Steril , vol.89 , pp. 84-91
    • Engmann, L.1    Diluigi, A.2    Schmidt, D.3    Nulsen, J.4    Maier, D.5    Benadiva, C.6
  • 10
    • 0028283354 scopus 로고
    • Early and late presentation of the ovarian hyperstimulation syndrome: Two distinct entities with different risk factors
    • Lyons D, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV. Early and late presentation of the ovarian hyperstimulation syndrome: Two distinct entities with different risk factors. Hum Reprod 1994;9:792-799
    • (1994) Hum Reprod , vol.9 , pp. 792-799
    • Lyons, D.1    Wheeler, C.A.2    Frishman, G.N.3    Hackett, R.J.4    Seifer, D.B.5    Haning, R.V.6
  • 11
    • 34247259868 scopus 로고    scopus 로고
    • Prevention and management of Ovarian Hyperstimulation Syndrome
    • DOI 10.1196/annals.1365.021, Women's Health and Disease: Gynecologic, Endocrine, and Reproductive Issues
    • Vlahos NF, Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann N Y Acad Sci 2006;1092:247-264 (Pubitemid 47092342)
    • (2006) Annals of the New York Academy of Sciences , vol.1092 , pp. 247-264
    • Vlahos, N.F.1    Gregoriou, O.2
  • 12
    • 0036827816 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade
    • DOI 10.1210/en.2002-220204
    • Gómez R, Simon C, Remohi J, Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology 2002;143:4339-4348 (Pubitemid 35239566)
    • (2002) Endocrinology , vol.143 , Issue.11 , pp. 4339-4348
    • Gomez, R.1    Simon, C.2    Remohi, J.3    Pellicer, A.4
  • 14
    • 0014385194 scopus 로고
    • Disappearance rate of endogenous luteinizing hormone and chorionic gonadotrophin in man
    • Yen SS, Llenera G, Little B, Pearson O. Disappearance rate of endogenous luteinizing hormone and chorionic gonadotrophin in man. J Clin Endocrinol Metab 1968;28:1763-1767
    • (1968) J Clin Endocrinol Metab , vol.28 , pp. 1763-1767
    • Yen, S.S.1    Llenera, G.2    Little, B.3    Pearson, O.4
  • 15
    • 0035793623 scopus 로고    scopus 로고
    • Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): A reassessment using novel receptor-specific vascular endothelial growth factor mutants
    • DOI 10.1074/jbc.M002016200
    • Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Ferrara N, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 2001;276:3222-30. (Pubitemid 37411615)
    • (2001) Journal of Biological Chemistry , vol.276 , Issue.5 , pp. 3222-3230
    • Gille, H.1    Kowalski, J.2    Li, B.3    LeCouter, J.4    Moffat, B.5    Zioncheck, T.F.6    Pelletier, N.7    Ferrara, N.8
  • 16
    • 0041842763 scopus 로고    scopus 로고
    • Regulation of vascular permeability by vascular endothelial growth factors
    • DOI 10.1016/S1537-1891(03)00011-9
    • Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002;39:225-237 (Pubitemid 37490748)
    • (2002) Vascular Pharmacology , vol.39 , Issue.4-5 , pp. 225-237
    • Bates, D.O.1    Harper, S.J.2
  • 17
    • 0037837014 scopus 로고    scopus 로고
    • Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability
    • DOI 10.1095/biolreprod.102.010801
    • Gómez R, Simón C, Remohí J, Pellicer A. Administration of moderate and high doses of gonadotrophins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003;68:2164-2171 (Pubitemid 36687009)
    • (2003) Biology of Reproduction , vol.68 , Issue.6 , pp. 2164-2171
    • Gomez, R.1    Simon, C.2    Remohi, J.3    Pellicer, A.4
  • 20
    • 32044459380 scopus 로고    scopus 로고
    • Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS
    • Gomez R, Gonzalez-Izquierdo M, Simon C, Remohi J, Pellicer A. Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS. Fertil Steril 2003;80:43-44
    • (2003) Fertil Steril , vol.80 , pp. 43-44
    • Gomez, R.1    Gonzalez-Izquierdo, M.2    Simon, C.3    Remohi, J.4    Pellicer, A.5
  • 21
    • 40449100155 scopus 로고    scopus 로고
    • Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: A pilot study
    • DOI 10.1093/humrep/dem315
    • Alvarez C, Alonso-Muriel I, García G, Crespo J, Bellver J, Simón C, et al. Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome (OHSS) in women undergoing ART. A pilot study. Hum Reprod 2007;22:3210-3214 (Pubitemid 351696781)
    • (2007) Human Reproduction , vol.22 , Issue.12 , pp. 3210-3214
    • Alvarez, C.1    Alonso-Muriel, I.2    Garcia, G.3    Crespo, J.4    Bellver, J.5    Simon, C.6    Pellicer, A.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.